All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Significant changes in the oral health of older patients have resulted in a partially dentate older population with decreased prevalence of edentulism \[[@pone.0203349.ref001]\]. In many counties, the current conventional care delivered to replace missing teeth for older patients involves provision of removable partial dentures (RPDs). However, less complex, functionally orientated treatment solutions are very applicable to partially dentate older patients including the Shortened Dental Arch (SDA) concept \[[@pone.0203349.ref002]\]. First described in 1981, the SDA approach aims to provide patients with a functional dentition of 10 occluding pairs of teeth or contacts without the need for a RPD \[[@pone.0203349.ref003]\]. Treatment efforts are focused on the anterior teeth which provides patients with an aesthetic dentition which can also be maintained successfully. Studies have shown that by providing 10 occluding pairs of teeth or contacts, patients can achieve suboptimal but acceptable levels of dental function \[[@pone.0203349.ref004],[@pone.0203349.ref005]\]. Evidence has shown that use of the SDA concept in older patients can have positive impacts on nutritional status and is more cost-effective to deliver and maintain than RPDs \[[@pone.0203349.ref006],[@pone.0203349.ref007]\]. However, evidence at the highest level remains extremely limited, with very few reported randomised trials reported.

Whilst a small number of patients will retain the 20 natural teeth necessary to achieve a SDA, it is more common for patients to be restored to a SDA. This can be done using a variety of fixed prosthodontic options including conventional bridgework, dental implants and adhesive resin bonded bridgework (RBB). RBB has been shown to be an effective and minimally invasive way of replacing missing teeth to provide patients with a SDA \[[@pone.0203349.ref008]\]. Despite the evidence in favour of the SDA concept it remains an underutilised approach \[[@pone.0203349.ref009]\].

The aim of this randomised clinical trial was to compare two different tooth replacement strategies for partially dentate older patients; namely functionally orientated treatment according to the principles of the shortened dental arch (SDA) and conventional treatment using removable partial dentures (RPDs). The primary outcome measure for this study was impact of the treatments on Oral Health-related Quality of Life (OHRQoL) measured using the short form of the Oral Health Impact Profile (OHIP-14). A secondary aim for this study was to report on the seven conceptional domains which make up summary OHIP-14 scores.

The null hypothesis for the study stated that patients treated according to the principles of the SDA would be no worse off than those treated using RPDs in terms of impact on OHRQoL.

Methodology {#sec006}
===========

The trial methodology has been described previously in other publications reporting on shorter follow up periods and secondary outcomes measures \[[@pone.0203349.ref002],[@pone.0203349.ref006],[@pone.0203349.ref007]\].

As illustrated in [Fig 1](#pone.0203349.g001){ref-type="fig"}, a randomised controlled clinical trial (RCT) was conducted. Patients were recruited from two centres: Cork University Dental Hospital (CUDH) and St Finbarr\'s Geriatric Day Hospital (SFDH) in Cork, Ireland. Recruitment ran from January 2011 until March 2013. Two year follow up data was collected from the last patient in May 2015. Patients were included in the study if they were 65 years or older and seeking replacement of missing natural teeth. Participants had a minimum of six remaining natural teeth in both arches of good prognosis, could accept routine dental care in a dental chair, could communicate in English and had no medical conditions which precluded routine dental treatment. Full ethical approval was granted for the study from the Cork Teaching Hospitals Ethics Committee (ref: ECM 5 (9) 05/02/08 [S1 Fig](#pone.0203349.s002){ref-type="supplementary-material"}). Each patient was provided with written information detailing the proposed treatment involved and each patient completed a written consent form prior to treatment. A power calculation was made based on summary OHIP-14 score data from the United Kingdom Adult Dental Health Survey \[[@pone.0203349.ref010]\]. The calculation was based on demonstrating that mean OHIP-14 in the RPD group was no worse than in the SDA group by a maximum of 4.0. The standard deviation used was 7.4, power was set at 80% with a one sided 5% level of significance. The power calculation indicated that 44 patients were required to complete the study from both treatment groups. The attrition rate was set at 30% to allow for drop outs during the study, so the targeted baseline recruitment was 130.

![Patient flow diagram.](pone.0203349.g001){#pone.0203349.g001}

Randomisation was performed using a computer generated schedule in SAS^®^. Patients were randomly allocated to two different treatment groups: the RPD group and the SDA group. Randomisation was conducted in blocks of varying length and was stratified according to age and gender. Separate randomisation schedules were generated for both recruitment site and the treatment groups included patients recruited from both centres, randomised independently. Patient randomisation was conducted by a research assistant and the allocation was concealed from the clinical operator. Initially, all patients received standardised dental care to render them dentally fit including extraction of hopeless teeth, restoration of caries and non surgical management of periodontal disease.

Patients from each treatment group received standardised care according to a treatment protocol. Each patient from the RPD group had all missing natural teeth replaced with RPDs fabricated with cobalt--chromium frameworks. Each patient from the SDA group was restored to a premolar occlusion of 10 occluding pairs of natural and replacement teeth using RBB throughout the arch. Posterior teeth distal to the SDA were left unopposed. The RBB was provided using a standardised protocol in each case. Each item of fixed and removable prosthodontics was constructed by the same dental laboratory. All operative treatment was conducted by a single operator with postgraduate training in clinical prosthodontics.

OHRQoL was measured using the OHIP-14 questionnaire \[[@pone.0203349.ref011]\]. The measure contains statements divided into seven theoretical domains, namely functional limitation, pain, psychological discomfort, physical disability, psychological disability, social disability and, handicap. As a cumulative record of negative impacts a reduction in OHIP-14 score represents an improvement in OHRQoL. The questionnaire was administered by a research nurse at baseline, 1 month, 6 months, 12 months and 24 months after treatment intervention. The research nurse was blinded to the treatment group allocation of all patients. Systemic comorbidity was recorded for each patient by a trained medical professional using the modified Cumulative Illness Rating Scale (CIRS) at baseline \[[@pone.0203349.ref012]\]. A measurement of social class was made for each patient using their longest held occupation. Patients were categorised according to the Registrar General\'s Social Classification \[[@pone.0203349.ref013]\].

Statistical analysis {#sec007}
--------------------

All variables recorded were summarised using appropriate descriptive statistics and graphics. Relationships between the treatment groups and mean summary OHIP-14 and OHIP-14 domain scores were assessed using linear models and logistic regression (binary and ordinal) models. Patient demographic variables (including age, gender, recruitment site, modified CIRS score and Social Class) were controlled for by including them in these models as covariates/factors. All variables recorded were presented by time-point and by treatment group. All patients were analysed according to initial treatment intent (determined by the randomisation process), not the treatment eventually administered. This was designed to reduce bias and to maintain the integrity of the randomisation process (intention-to-treat analysis).

The trial was registered retrospectively on ISRCTN (Registration number: 26302774). The authors confirm that all ongoing and related trials for this intervention are also registered.

Results {#sec008}
=======

The baseline characteristics of the study participants are presented in [Table 1](#pone.0203349.t001){ref-type="table"}.

10.1371/journal.pone.0203349.t001

###### Baseline characteristics of study participants.

![](pone.0203349.t001){#pone.0203349.t001g}

                    Patient Demographics                                                                                                   
  ----------------- ---------------------- ------ ---- ------ ------ ----- --- ------ ---- ------ ---- ------ ---- ------ ---- ------ ---- ----
  Treatment Group                                                                                                                          
  RPD               29                     44.6   36   55.4   74.1   6.2   2   3.1    18   27.7   25   38.5   10   15.4   9    13.9   15   12
  SDA               29                     43.3   38   56.7   73.9   7.0   6   16.4   11   16.4   24   35.8   11   16.4   13   19.4   17   17

OHIP-14 summary scores {#sec009}
----------------------

After 24 months, 89 participants completed the randomised controlled clinical trial. The mean OHIP-14 summary score for all patients are illustrated in [Table 2](#pone.0203349.t002){ref-type="table"} and [Fig 2](#pone.0203349.g002){ref-type="fig"}. A mixed model analysis of covariance (ANCOVA) for repeated measures was fitted to OHIP-14 summary scores. Fixed factors in the model were treatment group, time point (1, 6, 12 or 24 months), treatment centre, social class and gender. Within the model the covariates used were the baseline values, comorbidity scores and age ([Table 3](#pone.0203349.t003){ref-type="table"}). The two-level interactions between treatment group and each of time point, treatment centre, social class, gender, comorbidity scores and age were considered for inclusion. These were retained in the model only if significant at the 5% level of significance. Relevant three-level interactions based on the significant two-level interactions were also considered for inclusion. These were to be retained in the model only if significant at the 5% level of significance. The model assumptions were checked using residual analyses. Statistical analysis was performed using SAS® version 9.3 (SAS Institute Inc., Cary, North Carolina, USA).

![Mean OHIP-14 summary scores for all participants.](pone.0203349.g002){#pone.0203349.g002}

10.1371/journal.pone.0203349.t002

###### OHIP-14 scores recorded for all study participants.

![](pone.0203349.t002){#pone.0203349.t002g}

                                 Time Point                                                                                                 
  ------------------------------ ------------ ------- ------ ------ ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  **Summary OHIP-14 Score**      **Centre**   ** **   40     11.8   4.5   35    5.1   3.5   32    4.6   3.2   32    5.2   3.5   32    6.6   3.2
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           12.3    5.9    34     4.2   3.2   33    4.4   3.2   33    4.4   2.9   33    4.3   2.6         
  **Total**                      80           12.0    5.2    69     4.7   3.4   65    4.5   3.1   65    4.8   3.2   65    5.4   3.1         
  **SFDH**                       **RPD**      25      11.2   5.0    18    5.8   2.7   13    5.8   3.1   13    7.2   3.1   12    9.7   2.7   
  **SDA**                        27           11.7    4.9    18     3.4   2.4   14    2.9   2.0   14    3.0   1.4   12    3.0   1.1         
  **Total**                      52           11.4    4.9    36     4.6   2.8   27    4.3   3.0   27    5.0   3.2   24    6.3   4.0         
  **Total**                      **RPD**      65      11.5   4.7    53    5.4   3.3   45    4.9   3.2   45    5.8   3.5   44    7.4   3.3   
  **SDA**                        67           12.0    5.5    52     4.0   2.9   47    3.9   2.9   47    4.0   2.6   45    4.0   2.3         
  **Total**                      132          11.8    5.1    105    4.7   3.2   92    4.4   3.1   92    4.8   3.2   89    5.7   3.3         
  **Functional Limitation**      **Centre**   ** **   40     1.2    1.4   35    0.5   0.7   32    0.4   0.7   32    0.6   0.8   32    1.0   1.0
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           1.4     1.6    34     0.5   1.0   33    0.5   1.0   33    0.5   1.0   33    0.6   0.9         
  **Total**                      80           1.3     1.5    69     0.5   0.8   65    0.5   0.8   65    0.5   0.9   65    0.8   0.9         
  **SFDH**                       **RPD**      25      1.4    1.5    18    0.7   1.0   13    0.4   0.7   13    0.5   0.9   12    0.8   0.9   
  **SDA**                        27           1.1     1.2    18     0.3   0.6   14    0.4   0.6   14    0.4   0.6   12    0.6   0.5         
  **Total**                      52           1.3     1.3    36     0.5   0.8   27    0.4   0.6   27    0.4   0.8   24    0.7   0.8         
  **Total**                      **RPD**      65      1.3    1.4    53    0.6   0.8   45    0.4   0.7   45    0.5   0.8   44    0.9   0.9   
  **SDA**                        67           1.3     1.4    52     0.4   0.8   47    0.5   0.9   47    0.5   0.9   45    0.6   0.8         
  **Total**                      132          1.3     1.4    105    0.5   0.8   92    0.4   0.8   92    0.5   0.8   89    0.8   0.9         
  **Physical Pain**              **Centre**   ** **   40     3.1    1.7   35    2.0   1.4   32    1.9   1.5   32    2.0   1.4   32    2.3   1.3
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           2.7     1.4    34     1.5   1.5   33    1.5   1.5   33    1.6   1.4   33    1.6   1.2         
  **Total**                      80           2.9     1.6    69     1.7   1.5   65    1.7   1.5   65    1.8   1.4   65    2.0   1.3         
  **SFDH**                       **RPD**      25      3.2    1.9    18    2.6   1.5   13    3.2   1.4   13    3.5   1.2   12    3.7   1.2   
  **SDA**                        27           3.2     1.6    18     1.8   1.2   14    1.4   1.2   14    1.6   1.0   12    1.8   1.0         
  **Total**                      52           3.2     1.7    36     2.2   1.4   27    2.2   1.6   27    2.5   1.4   24    2.7   1.4         
  **Total**                      **RPD**      65      3.2    1.8    53    2.2   1.5   45    2.3   1.6   45    2.4   1.5   44    2.7   1.4   
  **SDA**                        67           2.9     1.5    52     1.6   1.4   47    1.5   1.4   47    1.6   1.3   45    1.6   1.2         
  **Total**                      132          3.0     1.6    105    1.9   1.5   92    1.9   1.5   92    2.0   1.4   89    2.2   1.4         
  **Psychological Discomfort**   **Centre**   ** **   40     2.8    1.7   35    1.1   1.1   32    1.0   1.1   32    1.2   1.3   32    1.2   1.3
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           3.3     2.1    34     0.9   1.1   33    0.9   1.1   33    0.9   1.0   33    0.8   0.9         
  **Total**                      80           3.0     1.9    69     1.0   1.1   65    0.9   1.1   65    1.0   1.1   65    1.0   1.1         
  **SFDH**                       **RPD**      25      2.3    1.9    18    0.8   1.1   13    0.5   1.0   13    1.5   1.7   12    1.3   1.6   
  **SDA**                        27           2.6     1.7    18     0.5   0.9   14    0.4   0.7   14    0.3   0.7   12    0.2   0.6         
  **Total**                      52           2.4     1.8    36     0.6   1.0   27    0.4   0.8   27    0.9   1.4   24    0.8   1.3         
  **Total**                      **RPD**      65      2.6    1.8    53    1.0   1.1   45    0.8   1.1   45    1.3   1.4   44    1.2   1.3   
  **SDA**                        67           3.0     2.0    52     0.7   1.0   47    0.7   1.0   47    0.7   0.9   45    0.6   0.9         
  **Total**                      132          2.8     1.9    105    0.9   1.1   92    0.8   1.1   92    1.0   1.2   89    0.9   1.2         
  **Physical Disability**        **Centre**   ** **   40     1.9    1.3   35    0.7   0.9   32    0.7   0.9   32    0.8   1.0   32    1.0   1.0
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           2.0     1.7    34     0.6   1.0   33    0.6   1.0   33    0.5   0.8   33    0.5   0.8         
  **Total**                      80           2.0     1.5    69     0.7   0.9   65    0.6   0.9   65    0.6   0.9   65    0.8   0.9         
  **SFDH**                       **RPD**      25      1.7    1.5    18    1.3   1.1   13    1.3   1.3   13    1.4   1.4   12    2.0   1.0   
  **SDA**                        27           2.4     1.2    18     0.6   0.8   14    0.6   0.7   14    0.6   0.6   12    0.4   0.5         
  **Total**                      52           2.1     1.4    36     1.0   1.0   27    1.0   1.1   27    1.0   1.1   24    1.2   1.1         
  **Total**                      **RPD**      65      1.8    1.4    53    0.9   1.0   45    0.9   1.0   45    1.0   1.1   44    1.3   1.1   
  **SDA**                        67           2.1     1.5    52     0.6   0.9   47    0.6   0.9   47    0.5   0.8   45    0.5   0.8         
  **Total**                      132          2.0     1.5    105    0.8   1.0   92    0.7   1.0   92    0.7   1.0   89    0.9   1.0         
  **Psychological Disability**   **Centre**   ** **   40     2.5    1.9   35    0.8   1.1   32    0.6   0.9   32    0.6   1.0   32    1.1   0.9
  **CUDH**                       **RPD**                                                                                                    
  **SDA**                        40           2.5     1.8    34     0.8   1.1   33    0.8   1.1   33    0.8   1.1   33    0.8   1.0         
  **Total**                      80           2.5     1.8    69     0.8   1.1   65    0.7   1.0   65    0.7   1.0   65    1.0   1.0         
  **SFDH**                       **RPD**      25      2.1    1.9    18    0.4   0.7   13    0.5   0.8   13    0.5   0.8   12    1.8   0.6   
  **SDA**                        27           2.1     1.8    18     0.2   0.7   14    0.1   0.3   14    0.1   0.3   12    0.1   0.3         
  **Total**                      52           2.1     1.8    36     0.3   0.7   27    0.3   0.6   27    0.3   0.6   24    1.0   1.0         
  **Total**                      **RPD**      65      2.4    1.9    53    0.6   1.0   45    0.6   0.9   45    0.6   0.9   44    1.3   0.9   
  **SDA**                        67           2.3     1.8    52     0.6   1.0   47    0.6   1.0   47    0.6   1.0   45    0.6   0.9         
  **Total**                      132          2.4     1.8    105    0.6   1.0   92    0.6   0.9   92    0.6   0.9   89    1.0   1.0         

10.1371/journal.pone.0203349.t003

###### Mixed model analysis of covariance (ANCOVA) for repeated measures fitted to OHIP-14 summary scores.

![](pone.0203349.t003){#pone.0203349.t003g}

  Effect                                    Numerator DF   Denominator DF   F Value   P-value
  ----------------------------------------- -------------- ---------------- --------- ---------------
  **Treatment Group**                       1              261              32.7      \< 0.0001
  **Baseline Score**                        1              261              21.9      \< 0.0001
  **Time Point**                            3              261              24.8      \< 0.0001
  **Treatment Centre**                      1              261              0.4       0.5271
  **Social Class**                          5              261              0.5       0.7923
  **Gender**                                1              261              0.7       0.4217
  **Comorbidity Score**                     1              261              1.5       0.2287
  **Age**                                   1              261              0.7       0.4199
  **Group\*Time Point**                     3              261              25.9      \< 0.0001
  **Group\*Treatment Centre**               1              261              10.1      0.0016
  **Group\*Time Point\*Treatment Centre**   6              261              6.4       **\< 0.0001**

There was an interaction between treatment group, time-point and treatment centre (p \< 0.0001). Therefore any difference in OHIP-14 summary scores between groups over time was not the same in the two centres. The group effect, time-point effect, centre effect and any of their two-level interactions cannot be interpreted in isolation. The groups were compared at each of the 3 time-points within each treatment centre separately. This analyses illustrated that the SDA group had better OHIP-14 scores compared to the RPD group in SFDH by an average of 2.7 at 1 month (p = 0.0056), 4.4 at 6 months (p \< 0.0001), 5.6 at 12 months (p \< 0.0001) and 7.9 at 24 months (p \< 0.0001). In CUDH the SDA and RPD groups recorded similar summary OHIP-14 scores at 1 month (p = 0.1824) and 6 months in (p = 0.1970). However, the SDA group had better OHIP-14 scores by an average of 1.4 at 12 months in CUDH (p = 0.0461) and 2.9 at 24 months in CUDH (p \< 0.0001). The model indicated that there was no difference between social classes (p = 0.7923) or genders recorded (p = 0.4217).

OHIP-14 domains {#sec010}
---------------

A mixed model analysis of covariance for repeated measures was fitted to the following OHIP-14 domains: Functional Limitation, Physical Pain, Psychological Discomfort, Physical Disability and Psychological Disability. Insufficient variability was present to allow further analysis of the following OHIP-14 domains: Social Disability and Handicap. As before, fixed factors in the model were treatment group, time point (1, 6, 12 or 24 months), treatment centre, social class and gender.

Within the model the covariates used were the baseline values, comorbidity scores and age. The two-level interactions between treatment group and each of time point, treatment centre, social class, gender, comorbidity scores and age were considered for inclusion. These were retained in the model only if significant at the 5% level of significance. Relevant three-level interactions based on the significant two-level interactions were also considered for inclusion. These were to be retained in the model only if significant at the 5% level of significance. The random effect used in the model was the patient with time-point as the repeated factor. The covariance structure applied was spatial power based on time-point. The model assumptions were checked using residual analyses. Square root transformations were required for Functional Limitation, Physical Disability and Psychological Disability to normalise and/or stabilise the residuals to ensure the assumptions underlying the statistical models were met. Differences in mean scores for statistically significant factors or interactions were estimated using appropriate contrasts within the analysis of covariance models.

### Functional limitation {#sec011}

At 24 months the SDA group reported lower scores of functional limitation by an average of 0.2 (p = 0.0316) compared to the RPD group ([Table 4](#pone.0203349.t004){ref-type="table"}). There were no significant differences recorded between the two treatment centres. For the RPD and SDA treatment groups, scores of functional limitation worsened slightly over time, with an average increase of 0.06 at 12 months (p = 0.0391) and a further increase of 0.2 at 24 months (p \< 0.0001).

10.1371/journal.pone.0203349.t004

###### Functional limitation domain scores for each treatment group.
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            Time-Point                                                                             
  --------- ------------ ----- ----- ---- ----- ----- ---- ----- ----- ---- ----- ----- ---- ----- -----
  **RPD**   65           1.3   1.4   53   0.6   0.8   45   0.4   0.7   45   0.5   0.8   44   0.9   0.9
  **SDA**   67           1.3   1.4   52   0.4   0.8   47   0.5   0.9   47   0.5   0.9   45   0.6   0.8

### Physical pain {#sec012}

Mean scores for physical pain are illustrated in [Table 2](#pone.0203349.t002){ref-type="table"}. In SFDH the SDA group reported lower physical pain scores by an average of 0.9 at 1 month (p = 0.0442), 2.4 at 6 months (p \< 0.0001), 2.4 at 12 months (p \< 0.0001), and 2.6 at 24 months (p \< 0.0001). In CUDH the functional and conventional groups reported similar physical pain scores at 1 month, 6 months, and 12 months, however, the functional group had lower scores by an average of 0.7 at 24 months (p = 0.0316).

### Psychological discomfort {#sec013}

Mean scores for psychological discomfort are illustrated in [Table 2](#pone.0203349.t002){ref-type="table"}. In SFDH the SDA and RPD groups reported similar psychological discomfort scores at 1 month and 6 months, however, the functional group had lower scores by an average of 1.6 at 12 months (p \< 0.0001), and 1.5 at 24 months (p = 0.0001). In CUDH the SDA and RPD groups reported similar psychological discomfort scores at 1 month and 6 months, however, the SDA group had lower scores by an average of 0.6 at 12 months (p \< 0.0001), and 0.6 at 24 months (p = 0.0001).

### Physical disability {#sec014}

The SDA group recorded lower physical disability scores by an average of 0.4 at 1 month (p = 0.0161), 0.4 at 6 months (p = 0.0280), 0.6 at 12 months (p = 0.0036), and 0.9 at 24 months (p = 0.0001). There was no significant differences recorded between the two treatment centres ([Table 2](#pone.0203349.t002){ref-type="table"}).

### Psychological disability {#sec015}

Mean scores for psychological disability are illustrated in [Table 2](#pone.0203349.t002){ref-type="table"}. In SFDH the SDA and RPD groups reported similar psychological disability scores at 1 month, however, the SDA group had lower scores by an average of 0.6 at 6 months (p = 0.0283), 0.6 at 12 months (p = 0.0308), and 1.9 at 24 months (p \< 0.0001). In CUDH the two treatment groups reported similar psychological disability scores at 1 month, 6 months, and 12 months, however, the SDA group had lower scores by an average of 0.5 at 24 months (p = 0.0047).

Discussion {#sec016}
==========

This study represents one of a very small number of clinical trials within clinical prosthodontics with a substantial follow up period. Furthermore, the use of a validated patient centred outcome, oral health-related quality of life, as the primary outcome measure is innovative in this field. It has been suggested that to promote patient-centred care, clinicians should measure the health status of their patients using standardised questionnaires and use this information to inform clinical decision making \[[@pone.0203349.ref014]\]. The oral health impact profile (OHIP) is a widely reported and validated tool used to capture oral health-related quality of life (OHRQoL) particularly amongst older adults \[[@pone.0203349.ref015],[@pone.0203349.ref016]\].

The results of this study illustrate that treatment according to the SDA concept resulted in significantly better mean OHIP-14 scores compared with RPD treatment for this group of partially dentate older patients, two years after treatment intervention. These results provide a longer and more meaningful follow up period compared with those previously reported from this study \[[@pone.0203349.ref002]\]. The results collected were consistent across both treatment centres where the SDA group recorded better mean OHIP-14 scores at all time points during the study. The results collected illustrate that the initial improvement in mean OHIP-14 score after 1 and 6 months was maintained in the SDA group through to 24 months. In comparison, the initial improvements observed in the RPD group began to be reversed after 6 months, particularly for those patients treated in SFDH. Thus, the benefit of SDA treatment appears to increase over time, particularly for those patients treated in SFDH.

Locker conceptualised that oral disease leads to oral ill-health through a sequence of inter-related domains \[[@pone.0203349.ref017]\]. The pain and functional limitation associated with oral impairment results in physical, psychological, and social disability, which in turn leads to patient handicap. OHIP-14 assesses each of these domains separately using two questions (e.g. "Have you had trouble pronouncing any words because of problems with your teeth, mouth or dentures?", as an assessment of functional limitation). Although in principle the reliability of an index falls with a reduction in the number of items, OHIP-14 has been shown to retain the original conceptual dimensions of the longer version OHIP-49 with good reliability, validity, and precision \[[@pone.0203349.ref011],[@pone.0203349.ref018]\].

A number of factors may explain these differences between treatment groups in the two treatment centres. Those patients in CUDH were treated in a conventional clinical environment within a modern tertiary healthcare centre with all of the advantages associated with this setting. Conversely, SFDH did not represent a typical dental clinical environment as patients were treated in a dental chair with a mobile dental unit. The mobile clinic was set up on each occasion and was not a permanent fixture in the geriatric day hospital. When not in use to provide dental services, the clinic was used to house podiatry and physiotherapy services. The patients themselves were also different with those treated in SFDH representing an older, more systemically unwell cohort. Many of the patients treated in SFDH were recovering from major medical conditions and often required transportation via ambulance to the hospital. Constructing fixed and removable prostheses were challenging in this environment but whilst RBB was often fabricated from a single good quality impression, RPDs required a larger number of complex clinical procedures over a longer timeframe \[[@pone.0203349.ref007]\].

This study adds further weight to the argument that functionally orientated tooth replacement is an acceptable treatment strategy for partially dentate older patients. The results reported were obtained using a gold standard methodology with a relatively low dropout rate. Previous work has already demonstrated that this approach can also have some positive impacts on nutritional status for partially dentate older patients \[[@pone.0203349.ref019]\]. Furthermore, it has been demonstrated that functionally orientated care is more cost effective to deliver and maintain compared to RPDs in this patient group \[[@pone.0203349.ref007]\]. The cost effectiveness analysis illustrated that the maintenance burden of patients with RPDs was significantly higher than those treated with the SDA. RPD patients returned for follow-up care more than three times more frequently compared with those in the SDA group (p\<0.001). Similar findings have been observed in other studies which have demonstrated increased maintenance burdens associated with RPDs compared to the SDA approach where patients have suffered from higher incidences of new carious lesions, periodontal breakdown and technical complications when treated with RPDs \[[@pone.0203349.ref020]--[@pone.0203349.ref023]\].

Given the increasing evidence in favour of functionally orientated tooth replacement for partially dentate older patients this may have policy implications for public and private healthcare providers. Currently many publically funded healthcare systems, including those in Ireland, do not financially support or remunerate the SDA treatment as described in this study. Treatment is currently focused on RPDs which may be increasingly inappropriate for this patient group. Further research is required to explore the external validity of the treatment approach described in this study, particularly in a primary care context.

Conclusion {#sec017}
==========

Patients in the SDA Group generally maintained their improvements in OHIP-14 scores throughout the 24 month study period. Patients in the RPD Group recorded initial improvements in OHrQOL but for many these began to diminish 6 months after treatment. The benefits of functionally orientated treatment appeared to increase over time, particularly for the older, more systemically unwell patient cohort treated in SFDH.
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